ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas

Clinical trial NCT03922555 · RECRUITING

Trial details

NCT number: NCT03922555
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Neurological Cancer

Start date: 2019-07-12
Primary completion: 2027-01-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.